These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 10208324

  • 1. Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference.
    Nestby P, Schoffelmeer AN, Homberg JR, Wardeh G, De Vries TJ, Mulder AH, Vanderschuren LJ.
    Psychopharmacology (Berl); 1999 Mar; 142(3):309-17. PubMed ID: 10208324
    [Abstract] [Full Text] [Related]

  • 2. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Vanderschuren LJ, Schoffelmeer AN, Wardeh G, De Vries TJ.
    Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
    [Abstract] [Full Text] [Related]

  • 3. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
    Kemppainen H, Raivio N, Suo-Yrjo V, Kiianmaa K.
    Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
    [Abstract] [Full Text] [Related]

  • 4. The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat.
    Lindholm S, Werme M, Brené S, Franck J.
    Behav Brain Res; 2001 May; 120(2):137-46. PubMed ID: 11182162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats.
    Zhai QZ, Ingenito AJ.
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):806-12. PubMed ID: 9641463
    [Abstract] [Full Text] [Related]

  • 7. Opioids in the perifornical lateral hypothalamus suppress ethanol drinking.
    Chen YW, Barson JR, Chen A, Hoebel BG, Leibowitz SF.
    Alcohol; 2013 Feb; 47(1):31-8. PubMed ID: 23199698
    [Abstract] [Full Text] [Related]

  • 8. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
    Powell KR, Holtzman SG.
    Eur J Pharmacol; 1999 Jul 14; 377(1):21-8. PubMed ID: 10448921
    [Abstract] [Full Text] [Related]

  • 9. Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.
    Henderson-Redmond A, Czachowski C.
    Psychopharmacology (Berl); 2014 Nov 14; 231(22):4309-21. PubMed ID: 24770627
    [Abstract] [Full Text] [Related]

  • 10. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
    Kuzmin A, Sandin J, Terenius L, Ogren SO.
    J Pharmacol Exp Ther; 2000 Dec 14; 295(3):1031-42. PubMed ID: 11082438
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular responses to kappa opioid agonists in intact and adrenal demedullated rats.
    Gulati A, Bhargava HN.
    Eur J Pharmacol; 1988 Nov 01; 156(2):247-57. PubMed ID: 2853675
    [Abstract] [Full Text] [Related]

  • 12. Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart.
    Zhang WM, Wu S, Yu XC, Wang HX, Bian JS, Wong TM.
    J Mol Cell Cardiol; 1999 Feb 01; 31(2):355-62. PubMed ID: 10093048
    [Abstract] [Full Text] [Related]

  • 13. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV, Johnson KJ, Proctor WR.
    Br J Pharmacol; 1987 Jul 01; 91(3):523-30. PubMed ID: 3038241
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1992 Jan 01; 260(1):327-33. PubMed ID: 1309876
    [Abstract] [Full Text] [Related]

  • 18. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
    Ko MC, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH.
    J Pharmacol Exp Ther; 1999 Dec 01; 291(3):1113-20. PubMed ID: 10565831
    [Abstract] [Full Text] [Related]

  • 19. Further study of kappa opioids on increased urination.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Oct 01; 227(1):35-41. PubMed ID: 6137557
    [Abstract] [Full Text] [Related]

  • 20. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ, Członkowski A, Lipkowski A, Herz A.
    J Pharmacol Exp Ther; 1989 Oct 01; 251(1):342-50. PubMed ID: 2571723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.